Leadership Bio

Mark Lelinski

Dartfrog Managing Director & Founder

Mark Lelinski is the Managing Director & Founder of Dartfrog Change Management, a unique consultancy focused exclusively on helping Life Sciences companies make transformative change happen.

Mark brings a breadth of experience in a variety of roles across the healthcare ecosystem – including the life science, payer, provider, retail pharmacy, specialty pharmacy, urgent care, and health technology sectors. Most recently, Mark was the VP of Global Commercial Operations at Gilead Sciences, where he led transformative change programs across the Commercial organization. Mark also played a leading role in launching Veklury (Remdesivir), the first approved therapeutic to fight COVID-19 in hospitalized patients. As the standard of care, Veklury has now been used to treat more than 10 million COVID-19 patients worldwide. 

Mark spent his formative years at AstraZeneca, where he led U.S. and global teams and served diverse markets around the world. Specifically, he has held executive level leadership positions in global marketing, commercial strategy, commercial operations and market access. Mark is known as an innovator who successfully manages and delivers large scale change with strong ROI impact. For example, he led the development of a first of its kind, Real World Evidence (RWE) capability, and has helped to completely redesign and re-imagine core functions such as Commercial and R&D.

Mark further diversified his experience in the industry when he served as the Corporate VP of Market Access for Walgreens $45B pharmacy, health and wellness business unit. He has also operated as the CEO of two health tech start-ups in the areas of biopharma artificial intelligence and patient engagement augmented reality. Early in his career, Mark was a Managing Director of Commercial Strategy in Life Sciences and Healthcare at Accenture, and also led the Change Management practice area with a focus on Life Sciences.

Mark operates from Norfolk, Virginia when not working with his Life Sciences clients around the globe.


At Dartfrog, we look forward to discussing your plans to make transformative change happen. Whether you need to reignite growth, accelerate product innovation, or digitize a new hybrid customer experience, we’d love to hear from you!